Evidence map›Paper›PMID 30989561›Full record

ArticleMolecular biology reports2019

Polyclonal predominance of concurrently producing OXA-23 and OXA-58 carbapenem-resistant Acinetobacter baumannii strains in a pediatric intensive care unit.

Theodoros Karampatakis, Katerina Tsergouli, Lida Politi, Georgia Diamantopoulou, Elias Iosifidis, Charalampos Antachopoulos, Aggeliki Karyoti, Maria Sdougka, Athanassios Tsakris, Emmanuel Roilides

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Carbapenem-ResistantMicroorganisms · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Theodoros KarampatakisInfectious Disease Unit, 3rd Department of Pediatrics, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Konstantinoupoleos 49, 546 42, Thessaloniki, Greece.
Katerina TsergouliMicrobiology Department, Hippokration General Hospital, Thessaloniki, Greece.
Lida PolitiMicrobiology Department, National and Kapodistrian University School of Medicine, Athens, Greece.
Georgia DiamantopoulouMicrobiology Department, National and Kapodistrian University School of Medicine, Athens, Greece.
Elias IosifidisInfectious Disease Unit, 3rd Department of Pediatrics, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Konstantinoupoleos 49, 546 42, Thessaloniki, Greece.
Charalampos AntachopoulosInfectious Disease Unit, 3rd Department of Pediatrics, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Konstantinoupoleos 49, 546 42, Thessaloniki, Greece.
Aggeliki KaryotiMicrobiology Department, Hippokration General Hospital, Thessaloniki, Greece.
Maria SdougkaPediatric Intensive Care Unit, Hippokration General Hospital, Thessaloniki, Greece.
Athanassios TsakrisMicrobiology Department, National and Kapodistrian University School of Medicine, Athens, Greece.
Emmanuel RoilidesInfectious Disease Unit, 3rd Department of Pediatrics, Medical Faculty, Aristotle University School of Health Sciences, Hippokration General Hospital, Konstantinoupoleos 49, 546 42, Thessaloniki, Greece. roilides@med.auth.gr.ORCID http://orcid.org/0000-0002-0202-364X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report a predominance (64.7%) of polyclonal carbapenem-resistant Acinetobacter baumannii (CRAB) strains concurrently producing OXA-23 and OXA-58 carbapenemases in a pediatric intensive care unit in an endemic area. This is the first report of emergence of such double-OXA CRAB strains in a single unit worldwide.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsDrug Resistance, BacterialHumansIntensive Care Units, PediatricMicrobial Sensitivity TestsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsAcinetobacter baumanniiCarbapenemsCritical careMicrobial resistancePediatrics

Identifiers

PMID30989561

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.